Corbus Pharmaceuticals

📍 Norwood, United States🗓 Founded 2014👥 50 employees💰 Last funded Dec 2013
Pharmaceutical Manufacturing🌐 corbuspharma.com
Website LinkedIn
Corbus is a precision oncology company committed to helping people defeat serious illness by bringing innovative scientific approaches to well understood biological pathways. Corbus’ internal development pipeline includes CRB-701, a next generation antibody drug conjugate (ADC) that targets the expression of Nectin 4-on cancer cells to release a cytotoxic payload and CRB-601, and anti-integrin monoclonal antibody which blocks the activation of TGFβ expressed on cancer cells. We are tenacious and will keep pushing the known boundaries to make breakthroughs where others have not.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2014
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Corbus Pharmaceuticals?
Corbus Pharmaceuticals has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Corbus Pharmaceuticals last raise funding?
The most recent investment in Corbus Pharmaceuticals recorded on gritt.io was in December 2013.
When was Corbus Pharmaceuticals founded?
Corbus Pharmaceuticals was founded in 2014.
What industry is Corbus Pharmaceuticals in?
Corbus Pharmaceuticals operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Corbus Pharmaceuticals based?
Corbus Pharmaceuticals is headquartered in Norwood, United States.